1-20 of 67
Sort by
News

Optimizing Treatment of Bleeding Episodes in Acquired Hemophilia A

Published: 2021
View News titled, Optimizing Treatment of Bleeding Episodes in Acquired Hemophilia A
News

Addition of Third Drug to Multiple Myeloma Regimen Slows Progression of Disease

Published: 2021
View News titled, Addition of Third Drug to Multiple Myeloma Regimen Slows Progression of Disease
News

PD-1 Checkpoint Inhibitors Harness the Immune System to Treat Lymphomas

Published: 2021
View News titled, PD-1 Checkpoint Inhibitors Harness the Immune System to Treat Lymphomas
News

Fusion Protein Therapies for Hemophilia A and B

Published: 2021
View News titled, Fusion Protein Therapies for Hemophilia A and B
News

Boosting Healthy Red Blood Cell Production to Target Anemia in MDS and Beta-Thalassemia

Published: 2021
View News titled, Boosting Healthy Red Blood Cell Production to Target Anemia in MDS and Beta-Thalassemia
News

AG-221 Clinical Results Promise “Revolutionary” Approach in AML

Published: 2021
View News titled, AG-221 Clinical Results Promise “Revolutionary” Approach in AML
News

Update on Idelalisib + Rituximab in Relapsed and Elderly CLL Patients

Published: 2021
View News titled, Update on Idelalisib + Rituximab in Relapsed and Elderly CLL Patients
News

Nilotinib Improves Prognosis in Elderly Patients with Ph+ ALL

Published: 2021
View News titled, Nilotinib Improves Prognosis in Elderly Patients with Ph+ ALL
News

New Treatment Option for Relapsed or Refractory Multiple Myeloma

Published: 2021
View News titled, New Treatment Option for Relapsed or Refractory Multiple Myeloma
News

Promising Results for Elotuzumab Push Monoclonal Antibody Into Phase 3 Trial

Published: 2021
View News titled, Promising Results for Elotuzumab Push Monoclonal Antibody Into Phase 3 Trial
News

New Drug Class Could Fill Unmet Need in Treatment of Multiple Myeloma

Published: 2021
View News titled, New Drug Class Could Fill Unmet Need in Treatment of Multiple Myeloma
News

Brentuximab Vedotin Delivers Clinical Results in Both Pre- and Post-Transplant Hodgkin Lymphoma

Published: 2021
View News titled, Brentuximab Vedotin Delivers Clinical Results in Both Pre- and Post-Transplant Hodgkin Lymphoma
News

Ibrutinib + Rituximab Benefits Patients With Pre-Treated Lymphoma and Leukemia

Published: 2021
View News titled, Ibrutinib + Rituximab Benefits Patients With Pre-Treated Lymphoma and Leukemia
News

IMWG Revises International Staging System for Multiple Myeloma

Published: 2021
View News titled, IMWG Revises International Staging System for Multiple Myeloma
News

Safety and Tolerability of MOR202 in Relapsed/Refractory Myeloma Patients

Published: 2021
View News titled, Safety and Tolerability of MOR202 in Relapsed/Refractory Myeloma Patients
News

Pinpointing the Mechanisms that Transform MGUS into Myeloma

Published: 2021
View News titled, Pinpointing the Mechanisms that Transform MGUS into Myeloma
News

Safety Profile of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients

Published: 2021
View News titled, Safety Profile of Daratumumab in Relapsed/Refractory Multiple Myeloma Patients
News

Recently Approved Agents

Published: 2021
View News titled, Recently Approved Agents
News

The Present and Future Multiple Myeloma Landscape

Published: 2021
View News titled, The Present and Future Multiple Myeloma Landscape
News

Carfilzomib Bests Bortezomib in Relapsed Multiple Myeloma

Published: 2021
View News titled, Carfilzomib Bests Bortezomib in Relapsed Multiple Myeloma